{"id":"https://openalex.org/W7225150615","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1055","title":"1055 Preclinical characterization of local and systemic pharmacodynamic biomarkers of AT-108, a first-in-class in situ tumor-to-dendritic cell reprogramming agent","display_name":"1055 Preclinical characterization of local and systemic pharmacodynamic biomarkers of AT-108, a first-in-class in situ tumor-to-dendritic cell reprogramming agent","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225150615","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1055"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.1055","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1055","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.1055","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1208.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A1208.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083961402","display_name":"Emma Leire","orcid":"https://orcid.org/0000-0001-9161-0442","observed_orcids":["https://orcid.org/0000-0001-9161-0442"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emma Leire","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093291983","display_name":"Fritiof \u00c5kerstr\u00f6m","orcid":"https://orcid.org/0009-0005-4071-3771","observed_orcids":["https://orcid.org/0009-0005-4071-3771"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Fritiof \u00c5kerstr\u00f6m","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sweden","Department of Clinical Sciences at Lund University, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sweden","institution_ids":[]},{"raw_affiliation_string":"Department of Clinical Sciences at Lund University, Lund, Sweden","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033417820","display_name":"Xavier Catena","orcid":"https://orcid.org/0000-0001-7885-2447","observed_orcids":["https://orcid.org/0000-0001-7885-2447"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xavier Catena","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160491958","display_name":"Simon Baumgart","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simon Baumgart","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053201277","display_name":"Ilia Kurochkin","orcid":"https://orcid.org/0000-0003-3100-0903","observed_orcids":["https://orcid.org/0000-0003-3100-0903","https://orcid.org/0000-0002-5706-8124"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ilia Kurochkin","raw_affiliation_strings":["Lund Stem Cell Centre at Lund University, Lund, Sweden","Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lund Stem Cell Centre at Lund University, Lund, Sweden","institution_ids":["https://openalex.org/I187531555"]},{"raw_affiliation_string":"Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sweden","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133883639","display_name":"Arun Sundaramurthy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arun Sundaramurthy","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076485844","display_name":"Anna Perego","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Perego","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133901002","display_name":"Ruixian Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruixian Liu","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070091581","display_name":"Camille Chatelain","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Camille Chatelain","raw_affiliation_strings":["Lund Stem Cell Centre at Lund University, Lund, Sweden","Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lund Stem Cell Centre at Lund University, Lund, Sweden","institution_ids":["https://openalex.org/I187531555"]},{"raw_affiliation_string":"Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sweden","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117709191","display_name":"Gaia Fontanari","orcid":"https://orcid.org/0009-0007-6151-8048","observed_orcids":["https://orcid.org/0009-0007-6151-8048"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Gaia Fontanari","raw_affiliation_strings":["Lund Stem Cell Centre at Lund University, Lund, Sweden","Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lund Stem Cell Centre at Lund University, Lund, Sweden","institution_ids":["https://openalex.org/I187531555"]},{"raw_affiliation_string":"Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sweden","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133834483","display_name":"Lihan Xie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lihan Xie","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103325041","display_name":"Xiaoli Huang","orcid":"https://orcid.org/0009-0009-0005-7860","observed_orcids":["https://orcid.org/0009-0009-0005-7860"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoli Huang","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042449765","display_name":"Shane Anthony Olwill","orcid":"https://orcid.org/0009-0009-8816-1784","observed_orcids":["https://orcid.org/0009-0009-8816-1784"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shane Olwill","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082399462","display_name":"Cristiana F. Pires","orcid":"https://orcid.org/0000-0003-2985-6323","observed_orcids":["https://orcid.org/0000-0003-2985-6323"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cristiana F Pires","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159347344","display_name":"Filipe Pereira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]},{"id":"https://openalex.org/I76903346","display_name":"University of Coimbra","ror":"https://ror.org/04z8k9a98","country_code":"PT","type":"education","lineage":["https://openalex.org/I76903346"]}],"countries":["PT","SE"],"is_corresponding":false,"raw_author_name":"Filipe Pereira","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sweden","Lund Stem Cell Centre at Lund University, Lund, Sweden","University of Coimbra, Coimbra, Portugal","Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sweden","institution_ids":[]},{"raw_affiliation_string":"Lund Stem Cell Centre at Lund University, Lund, Sweden","institution_ids":["https://openalex.org/I187531555"]},{"raw_affiliation_string":"University of Coimbra, Coimbra, Portugal","institution_ids":["https://openalex.org/I76903346"]},{"raw_affiliation_string":"Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sweden","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5133884855","display_name":"Fabio Rosa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fabio Rosa","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sweden","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1208","last_page":"A1208"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dendritic-cell-reprogramming","display_name":"dendritic cell reprogramming","score":0.7710000276565552},{"id":"https://openalex.org/keywords/antigen-presentation","display_name":"antigen presentation","score":0.5640000104904175},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-resistance","display_name":"immune checkpoint inhibitor resistance","score":0.8019999861717224},{"id":"https://openalex.org/keywords/pharmacodynamic-markers","display_name":"pharmacodynamic biomarkers","score":0.6899999976158142},{"id":"https://openalex.org/keywords/pu-1","display_name":"PU.1","score":0.7400000095367432},{"id":"https://openalex.org/keywords/irf8","display_name":"IRF8","score":0.9800000190734863},{"id":"https://openalex.org/keywords/batf3","display_name":"Batf3","score":0.9980000257492065},{"id":"https://openalex.org/keywords/adenovirus-vectors","display_name":"adenoviral vector","score":0.7580000162124634},{"id":"https://openalex.org/keywords/tumor-microenvironment-remodeling","display_name":"tumor microenvironment remodeling","score":0.949999988079071},{"id":"https://openalex.org/keywords/interferon-signaling","display_name":"interferon signaling","score":0.8889999985694885},{"id":"https://openalex.org/keywords/tertiary-lymphoid-structures","display_name":"tertiary lymphoid structures","score":0.8529999852180481},{"id":"https://openalex.org/keywords/bcl6","display_name":"BCL6","score":0.47099998593330383},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.5759999752044678},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.6480000019073486},{"id":"https://openalex.org/keywords/abscopal-effect","display_name":"abscopal effect","score":0.5659999847412109}],"concepts":[{"id":"https://openalex.org/C77255625","wikidata":"https://www.wikidata.org/wiki/Q402093","display_name":"Reprogramming","level":3,"score":0.6582000255584717},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5649999976158142},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5576000213623047},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5562000274658203},{"id":"https://openalex.org/C2777822432","wikidata":"https://www.wikidata.org/wiki/Q216681","display_name":"In situ","level":2,"score":0.4787999987602234},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.36959999799728394},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33329999446868896},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.2851000130176544},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.2773999869823456},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.2759999930858612},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2736000120639801},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25920000672340393}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.1055","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1055","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.1055","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1208.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:a97613ae9c7744259226b88ace507eff","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/a97613ae9c7744259226b88ace507eff","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 14, Iss Suppl 2 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.1055","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1055","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.1055","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1208.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225150615.pdf","grobid_xml":"https://content.openalex.org/works/W7225150615.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7154684215","https://openalex.org/W7225178714","https://openalex.org/W2601312206","https://openalex.org/W7063915289","https://openalex.org/W2538095839","https://openalex.org/W7225195518","https://openalex.org/W4403204387","https://openalex.org/W4402022195","https://openalex.org/W4281255808","https://openalex.org/W7225136469"],"abstract_inverted_index":{"Background":[0],"Defective":[1],"antigen":[2],"presentation":[3],"and":[4,17,38,61,70,94,103,122,132,136,149,153,163,166,199,213,263,274,294,304,316,326,340,357,359,385,392,401,412,445,462,480,525],"scarcity":[5],"of":[6,55,194,230,288,321,367,447],"conventional":[7,518],"type":[8,195,200,323],"1":[9],"dendritic":[10,520,537],"cells":[11,44,232,271,431,521],"(cDC1s)":[12],"contribute":[13],"to":[14,19,85,183,220,459,474],"cancer":[15,361,497,541],"progression":[16],"resistance":[18],"immune":[20,96,215,328,338,368,394,501,523],"checkpoint":[21,409,502],"blockade":[22,503],"(ICB).":[23],"1\u20136":[24],"We":[25],"have":[26],"developed":[27],"AT-108,":[28],"a":[29,128,377],"replication-deficient":[30],"adenoviral":[31,130,224],"vector":[32,131],"encoding":[33],"transcription":[34],"factors":[35],"PU.1,":[36],"IRF8,":[37],"BATF3":[39],"(PIB)":[40],"that":[41,387],"reprograms":[42],"tumor":[43,68,90,161,178,345,390,424,527],"into":[45],"professional":[46],"antigen-presenting":[47,430],"cDC1-like":[48],"cells.":[49],"In":[50,535],"preclinical":[51],"models,":[52,125],"intratumoral":[53,255],"delivery":[54,152],"AT-108":[56,75,108,110,151,388],"resulted":[57],"in":[58,66,115,160,169,307,354,382,478,493],"monotherapy":[59,114],"efficacy":[60],"synergy":[62],"with":[63,107,127,177,222,233,239,286,331,336,350,517],"ICB,":[64],"resulting":[65],"complete":[67],"regression":[69],"abscopal":[71],"antitumor":[72],"responses.7":[73],"As":[74],"advances":[76],"towards":[77],"first-in-human":[78],"studies,":[79],"translational":[80,101,365,378],"pharmacodynamic":[81,281],"biomarkers":[82,105],"are":[83],"needed":[84],"demonstrate":[86,386],"delivery,":[87],"transgene":[88,154,181],"expression,":[89,389],"microenvironment":[91],"(TME)":[92],"remodeling,":[93,190],"systemic":[95,337,393],"activation.":[97],"Here,":[98],"we":[99],"identified":[100,319],"tumor-":[102,400],"blood-based":[104,402],"associated":[106,349],"activity.Methods":[109],"was":[111,247],"evaluated":[112],"as":[113],"the":[116,364,423,453,551],"syngeneic":[117],"ICB-resistant":[118],"T-cell":[119],"LOW":[120],"B16":[121],"T-cellMEDIUM":[123],"YUMM1.7":[124],"compared":[126,219],"non-coding":[129],"PBS":[133],"controls.":[134],"Tumor":[135,454,457],"blood":[137,309,314],"samples":[138],"were":[139,156,283,348,548],"analyzed":[140],"using":[141],"RT-ddPCR,":[142],"RNA":[143,167],"sequencing,":[144],"flow":[145,250,311],"cytometry,":[146,251],"plasma":[147,317],"proteomics,":[148],"immunofluorescence.Results":[150],"expression":[155,182],"confirmed":[157,248],"by":[158,164,192,249,310,371,550],"immunofluorescence":[159],"sections,":[162],"RT-ddPCR":[165],"sequencing":[168],"dissociated":[170],"tumors.":[171],"PIB":[172],"transcript":[173],"levels":[174],"inversely":[175],"correlated":[176],"burden,":[179],"linking":[180],"therapeutic":[184],"activity.":[185],"Transcriptomic":[186],"profiling":[187],"revealed":[188],"TME":[189,245],"characterized":[191],"induction":[193,320],"I":[196,324],"(OASL2,":[197],"IRF7)":[198],"II":[201],"(IFNGR1,":[202],"STAT4,":[203],"TBX21)":[204],"interferon":[205],"signaling,":[206],"cytotoxic":[207,259],"lymphocyte":[208],"programs":[209,329,369],"(GZMB,":[210],"CCR7,":[211],"CD40LG),":[212],"humoral":[214,327],"responses":[216],"(LTB,":[217],"IGHG2C),":[218],"treatment":[221],"control":[223],"vector.":[225],"Immunofluorescence":[226],"also":[227],"showed":[228,253],"co-localization":[229],"AT-108-tranduced":[231],"BCL6":[234],"+":[235],"lymphoid":[236],"aggregates,":[237],"consistent":[238,335],"immunogenic":[240],"tertiary":[241],"lymphoid-like":[242],"structure":[243],"formation.":[244],"remodeling":[246,391],"which":[252],"increased":[254,332],"T-bet+PD-1-":[256],"effector,":[257,289],"Gzmb+":[258],"CD8+":[260],"T":[261,270,297,434],"cells,":[262,298,303],"CXCR5+":[264,299],"PD-1+":[265,301],"germinal":[266],"center":[267],"follicular":[268],"helper":[269],"(Tfh),":[272],"DCs":[273,305],"reduced":[275],"immunosuppressive":[276],"Arg-1+/PD-L1+":[277],"myeloid":[278,425],"populations.":[279],"These":[280],"changes":[282],"mimicked":[284],"systemically,":[285],"expansion":[287],"cytotoxic,":[290],"CD44+":[291],"CD62L+":[292],"memory,":[293],"Ki67+":[295],"proliferating":[296],"ICOS+":[300],"Tfh":[302],"measured":[306],"peripheral":[308],"cytometry.":[312],"Integrated":[313],"transcriptomics":[315],"proteomics":[318],"mitochondrial,":[322],"interferon,":[325],"together":[330],"circulating":[333],"immunoglobulins,":[334],"activation":[339,395],"B-cell":[341],"engagement.":[342],"Finally,":[343],"AT-108-induced":[344],"transcriptional":[346],"signatures":[347],"improved":[351],"overall":[352],"survival":[353],"human":[355],"melanoma":[356],"head":[358],"neck":[360],"datasets,":[362],"supporting":[363],"relevance":[366],"activated":[370],"AT-108.Conclusions":[372],"Together,":[373],"these":[374],"findings":[375],"establish":[376],"biomarker":[379],"framework":[380],"for":[381,433,540],"situ":[383],"cDC1reprogramming":[384],"can":[396],"be":[397],"monitored":[398],"through":[399],"biomarkers.References":[403],"Sharma":[404],"P,":[405],"et":[406,420,442,468,488,514,533],"al.":[407,421,443,469,489,515,534],"Immune":[408],"therapy\u2014current":[410],"perspectives":[411],"future":[413],"directions.":[414],"Cell.":[415,438],"2023;186:1652\u20131669.":[416],"Broz":[417],"M.":[418],"L,":[419],"Dissecting":[422],"compartment":[426],"reveals":[427],"rare":[428],"activating":[429],"critical":[432],"cell":[435,491,538],"immunity.":[436],"Cancer":[437,484],"2014;26:638\u201352.":[439],"Salmon":[440],"H,":[441],"Expansion":[444],"Activation":[446],"CD103+":[448],"Dendritic":[449,471,490],"Cell":[450,472],"Progenitors":[451],"at":[452],"Site":[455],"Enhances":[456],"Responses":[458],"Therapeutic":[460],"PD-L1":[461],"BRAF":[463],"Inhibition.":[464],"Immunity.":[465],"2016;44:924\u2013938.Saito":[466],"S,":[467],"Targeting":[470],"Dysfunction":[473],"Circumvent":[475],"Anti-PD1":[476],"Resistance":[477],"Head":[479],"Neck":[481],"Cancer.":[482],"Clinical":[483],"Research.":[485],"2024;30:1934.Ho":[486],"WW,":[487],"paucity":[492],"mismatch":[494],"repair-proficient":[495],"colorectal":[496],"liver":[498],"metastases":[499],"limits":[500,526],"efficacy.":[504],"Proc.":[505],"Natl.":[506],"Acad.":[507],"Sci.":[508],"U.":[509],"S.":[510],"A.":[511],"2021;118:e2105323118.Heras-Murillo":[512],"I,":[513],"Immunotherapy":[516],"type-1":[519],"induces":[522],"memory":[524],"relapse.":[528],"Nature":[529],"Communications.":[530],"2025;16(1):16\u20133369.Ascic":[531],"E,":[532],"vivo":[536],"reprogramming":[539],"immunotherapy.":[542],"Science.":[543],"2024.Ethics":[544],"Approval":[545],"Animal":[546,554],"experiments":[547],"approved":[549,560,566],"Swedish":[552],"Malm\u00f6\u2013Lund":[553],"Research":[555],"Ethics":[556],"Committee":[557],"(Dnr":[558],"5.8.18-19343/2017,":[559],"February":[561],"28,":[562],"2018;":[563],"Dnr":[564],"5.8.18-06921/2025,":[565],"May":[567],"21,":[568],"2025).":[569]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-04T00:00:00"}